🌟 New Episode Alert: "𝗪𝗵𝗮𝘁’𝘀 𝗡𝗲𝘄 𝗗𝗼𝗰? 𝗶𝗻 𝗕𝗿𝗲𝗮𝘀𝘁 𝗖𝗮𝗻𝗰𝗲𝗿" 🌟 Join Prof Evandro de Azambuja and Dr Kevin Punie as they explore the 5-year update of the KEYNOTE-522 trial. This episode focuses on pembrolizumab's role in treating high-risk TNBC patients, highlighting significant advancements in EFS and treatment outcomes. 👇 View all WND Breast videos - link in the comments! #MediMix #BreastCancer #TNBC
https://bit.ly/3sZvoWu